[go: up one dir, main page]

NO20062248L - Rontgenkontrastmedium inneholdende liposom og fremgangsmate for fremstilling derav. - Google Patents

Rontgenkontrastmedium inneholdende liposom og fremgangsmate for fremstilling derav.

Info

Publication number
NO20062248L
NO20062248L NO20062248A NO20062248A NO20062248L NO 20062248 L NO20062248 L NO 20062248L NO 20062248 A NO20062248 A NO 20062248A NO 20062248 A NO20062248 A NO 20062248A NO 20062248 L NO20062248 L NO 20062248L
Authority
NO
Norway
Prior art keywords
medium
iodine compound
contrast medium
liposomes
lipid membrane
Prior art date
Application number
NO20062248A
Other languages
English (en)
Norwegian (no)
Inventor
Eiichi Ueda
Satoshi Kawakatsu
Akihisa Nakajima
Chiaki Nagaike
Original Assignee
Konica Minolta Med & Graphic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konica Minolta Med & Graphic filed Critical Konica Minolta Med & Graphic
Publication of NO20062248L publication Critical patent/NO20062248L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20062248A 2003-10-21 2006-05-18 Rontgenkontrastmedium inneholdende liposom og fremgangsmate for fremstilling derav. NO20062248L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2003360769 2003-10-21
JP2003382983 2003-11-12
JP2003392678 2003-11-21
JP2003392679 2003-11-21
JP2004085168A JP2005170923A (ja) 2003-10-21 2004-03-23 リポソーム含有ｘ線造影剤およびその製造方法
PCT/JP2004/005261 WO2005037325A1 (fr) 2003-10-21 2004-04-13 Produit de contraste radiographique contenant un liposome et procede de preparation dudit produit

Publications (1)

Publication Number Publication Date
NO20062248L true NO20062248L (no) 2006-05-18

Family

ID=34468536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062248A NO20062248L (no) 2003-10-21 2006-05-18 Rontgenkontrastmedium inneholdende liposom og fremgangsmate for fremstilling derav.

Country Status (6)

Country Link
US (1) US20050084453A1 (fr)
EP (1) EP1679084A1 (fr)
JP (1) JP2005170923A (fr)
CN (1) CN1929868B (fr)
NO (1) NO20062248L (fr)
WO (1) WO2005037325A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713517B2 (en) 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
WO2006009022A1 (fr) * 2004-07-21 2006-01-26 Konica Minolta Medical & Graphic, Inc. Colorant radio-opaque à rayons x contenant des liposomes, et processus de production
JP5176320B2 (ja) * 2004-08-11 2013-04-03 コニカミノルタエムジー株式会社 リポソーム含有製剤の製造方法
CA2596595C (fr) 2005-02-11 2014-12-16 University Health Network Compositions et procedes d'imagerie multimodale
US20060239925A1 (en) * 2005-04-21 2006-10-26 Konica Minolta Medical & Graphic, Inc. Method of manufacturing pharmaceutical preparation containing liposomes
EP2153820A4 (fr) * 2007-05-14 2013-12-25 Konica Minolta Holdings Inc Liposome et son procédé de préparation
EP2410990A4 (fr) * 2009-03-19 2015-05-20 Marval Biosciences Inc Compositions et procédés d'amélioration des contrastes en imagerie
RU2012138280A (ru) * 2010-03-23 2014-04-27 ДжиИ Хелткер АС Получение стабилизированной диагностической композиции для рентгеновского исследования
DK2710035T3 (en) 2011-05-16 2017-06-19 Hoffmann La Roche FGFR1 agonists and methods of use
US20140161876A1 (en) * 2011-07-15 2014-06-12 Konica Minolta, Inc. Liposome-containing preparation utilizing dissolution aid, and method for producing same
WO2013151650A1 (fr) * 2012-04-05 2013-10-10 University Of Florida Research Foundation, Inc. Nanoparticules neurophiles

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
CA1264668A (fr) * 1984-06-20 1990-01-23 Pieter R. Cullis Techniques d'extrusion pour la production de liposomes
EP0285638A4 (fr) * 1986-09-18 1989-06-14 Liposome Technology Inc Procede de traitement d'un liposome a concentration elevee.
CH672733A5 (fr) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
JPH01249717A (ja) * 1988-03-30 1989-10-05 Fuji Photo Film Co Ltd リポソームの製造方法
WO1992005772A1 (fr) * 1990-10-05 1992-04-16 The Liposome Company, Inc. Procede d'extrusion de liposomes
JP2837305B2 (ja) * 1992-01-17 1998-12-16 日清製油株式会社 安定化剤
JP2854203B2 (ja) * 1992-09-03 1999-02-03 株式会社ディ・ディ・エス研究所 リポソームの製造法
US5326552A (en) * 1992-12-17 1994-07-05 Sterling Winthrop Inc. Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
US5554382A (en) * 1993-05-28 1996-09-10 Aphios Corporation Methods and apparatus for making liposomes
JP3498339B2 (ja) * 1993-12-16 2004-02-16 日本油脂株式会社 リン脂質誘導体
JP3759765B2 (ja) * 1994-03-28 2006-03-29 第一製薬株式会社 リポソーム
AU2076895A (en) * 1994-03-28 1995-10-17 Daiichi Pharmaceutical Co., Ltd. Liposomes
JP3391151B2 (ja) * 1995-06-21 2003-03-31 日本油脂株式会社 コレステロール誘導体
DE19648650C2 (de) * 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung
EP0914094A4 (fr) * 1996-03-28 2000-03-01 Univ Illinois Materiaux et procedes destines a la preparation de compositions de liposomes ameliorees
JP4710109B2 (ja) * 2000-07-24 2011-06-29 日油株式会社 ポリアルキレンオキシド修飾リン脂質、その製造方法および用途
US20040099976A1 (en) * 2000-10-13 2004-05-27 Katsuto Otake Process for producing liposome and apparatus therefor
JP2003119120A (ja) * 2001-10-12 2003-04-23 Masahiko Abe リポソームの製造方法、及び該リポソームを含有する化粧料、及び皮膚外用剤

Also Published As

Publication number Publication date
US20050084453A1 (en) 2005-04-21
CN1929868A (zh) 2007-03-14
JP2005170923A (ja) 2005-06-30
EP1679084A1 (fr) 2006-07-12
CN1929868B (zh) 2010-11-24
WO2005037325A1 (fr) 2005-04-28

Similar Documents

Publication Publication Date Title
NO20062248L (no) Rontgenkontrastmedium inneholdende liposom og fremgangsmate for fremstilling derav.
McComb et al. Investigations on the influence of headgroup substitution and isoprene side-chain length in the function of primary and secondary quinones of bacterial reaction centers
Sawada et al. Peptide [4] catenane by folding and assembly
Fortunato et al. Liquid membranes using ionic liquids: the influence of water on solute transport
Hao et al. Studies on a high encapsulation of colchicine by a niosome system
Ansari et al. Solubilization of polycyclic aromatic hydrocarbons by novel biodegradable cationic gemini surfactant ethane-1, 2-diyl bis (N, N-dimethyl-N-hexadecylammoniumacetoxy) dichloride and its binary mixtures with conventional surfactants
Tsuchiya et al. Interaction of galvinoxyl radical with ascorbic acid, cysteine, and glutathione in homogeneous solution and in aqueous dispersions.
da Silva Júnior et al. The evaluation of quinonoid compounds against Trypanosoma cruzi: Synthesis of imidazolic anthraquinones, nor-β-lapachone derivatives and β-lapachone-based 1, 2, 3-triazoles
Leite et al. Cholesterol modulates curcumin partitioning and membrane effects
IS6451A (is) Nýjar 1,3-díhýdró-2H-indól-2-ón afleiður, framleiðsluaðferð og lyfjasamsetningar sem innihalda þær
Pramauro et al. Micelles: a new dimension in analytical chemistry
Dhingra et al. Formation of water-in-oil microemulsions within a hydrophobic deep eutectic solvent
NO20070939L (no) Liposominneholdende radiografisk konstrastmedium og fremstillingfremgangsmate for dette.
Gubernator et al. Dual effect of alkylresorcinols, natural amphiphilic compounds, upon liposomal permeability
FR2864900B1 (fr) Dispersion aqueuse de nanocapsules a coeur huileux
Selinsky et al. The aminosterol antibiotic squalamine permeabilizes large unilamellar phospholipid vesicles
Yamaguchi et al. Preparation of nonionic vesicles using the supercritical carbon dioxide reverse phase evaporation method and analysis of their solution properties
Geßner et al. Ionophore and anthelmintic activity of PF 1022A, a cyclooctadepsipeptide, are not related
Mayer et al. Independence of substituent contributions to the transport of small-molecule permeants in lipid bilayer
Katayama et al. Preparation of novel double liposomes using the glass-filter method
Giudice et al. The amphiphilic alkyl ester derivatives of L-ascorbic acid induce reorganization of phospholipid vesicles
Gopinath et al. 1-O-Alkylglycerol vesicles (Algosomes): their formation and characterization
Loghin et al. Effects of some antioxidative aporphine derivatives on striatal dopaminergic transmission and on MPTP-induced striatal dopamine depletion in B6CBA mice
Tsuji et al. Effects of surfactants on the aqueous stability and solubility of β-lactam antibiotics
Annese et al. Oxidation-proof microemulsions: Microstructure and reactivity in the presence of dioxiranes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application